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Differentiationchaperone Grp94 is required for the cell surface export of molecules involved in
the native immune response, in mesoderm induction and muscle development, but the signals responsible
for Grp94 recruitment are still obscure. Here we show for the ﬁrst time that Grp94 undergoes Tyr-
phosphorylation in differentiating myogenic C2C12 cells. By means of phospho-proteomic and immunopre-
cipitation analyses, and the use of Src-speciﬁc inhibitors we demonstrate that the Src-tyrosine-kinase Fyn
becomes active early after induction of C2C12 cell differentiation, in parallel with the recruitment and the
Tyr-phosphorylation of Grp94, which peaks at 6-hour differentiation. Grp94 is Tyr-phosphorylated inside the
endoplasmic reticulum by a lumenal Fyn, as indicated by ﬂuorescence and electronmicroscopy
immunolocalization, co-immunoprecipitation after chemical cross-linking and by treatment of intact
endoplasmic-reticulum vesicles with proteinase K. Furthermore, fractionation of cellular membrane
compartments and double-immunoﬂuorescence studies showed that Tyr-phosphorylation of Grp94 is
necessary for the protein translocation from the endoplasmic reticulum to the Golgi apparatus. These results
indicate that Fyn-catalyzed Tyr-phosphorylation of Grp94 is an event required to promote the chaperone
export from the endoplasmic reticulum occurring in the early phase of myoblast differentiation.
© 2008 Elsevier B.V. All rights reserved.1. IntroductionThe glucose-regulated protein Grp94/gp96 is an endoplasmic
reticulum (ER) chaperone of the heat shock protein family (an
Hsp90 homologue), which is upregulated together with Grp78 in
response to ER stress and is responsible for relevant pro-survival
effects [1–4]. Grp94 operates as a dimer in a large multi-protein
complex together with Grp78, providing a platform for the assembly
or oligomerization of loaded protein cargo [5]. In particular, Grp94/
gp96 is required for the cell surface export of cell receptors involved in
the native immune response [6,7] and for the secretion of growth
factors involved in mesoderm induction and muscle development [8].
Furthermore, Grp94 can exist both as a transmembrane and a luminal
ER protein [9,10] and localizes on the surface of tumoral and normal
cells, among which are exocrine pancreatic cells, differentiating
skeletal muscle myocytes, murine immature thymocytes and amphi-
bian and teleost lymphocytes [11–15].iologica, Viale G. Colombo 3,
8073310.
-Deana).
l rights reserved.An additional under-explored feature of Grp94 is the occurrence of
either constitutive or inducible phosphorylation of the chaperone.
Constitutive Grp94 phosphorylationwas detected in a limited number
of neoplastic and non-neoplastic cell lines, including SV-40 trans-
formed rat-1 cells, L6 differentiating myoblasts, NRK and Sf21 cells
[16–18], whereas inducible Grp94 phosphorylation was achieved in
lung alveolar human cells exposed to lithium [19]. Although the
Ser/Thr speciﬁc protein kinase CK2 and Golgi casein-kinase were
identiﬁed in vitro as potentially responsible for Grp94 phosphoryla-
tion in cardiomyocytes and in mammary glands [20,21], other protein
kinases might be involved as well. For instance, other ER chaperones
and members of the Grp family, such as Grp58 and Grp75, were
found to undergo Tyr-phosphorylation [22–25].
Among the tyrosine-kinases that operate within the cells, this
study focuses on Src tyrosine kinases and was aimed at analyzing
whether these kinases phosphorylated Grp94 and played a role in this
chaperone biology. The rationale to investigate about the possible
relationship between Src-kinases and Grp94 was given by the
independent ﬁndings, provided by us and derived from the literature,
concerning their relevant role inmuscle differentiation.We previously
showed that Grp94 localizes at the cell surface of differentiating
skeletal muscle cells, where the protein is required formyoblast fusion
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cardiac or skeletal muscle cell can develop in Grp94−/− embryos [8].
Also Src-kinases were found to play relevant roles in skeletal muscle
cell biology. Src family consists of at least nine non-receptor tyrosine
kinases (Src, Lyn, Fyn, Fgr, Lck, Hck, Yes, Yrk and Blk), which regulate a
wide spectrum of events [reviewed in 26,27]. In skeletal muscle, Src-
kinases stimulate myoblast proliferation and the clustering of
acetylcholine receptors during development of the neuromuscular
junctions [28,29]. In particular, Fyn activity is required for the survival
of differentiated myotubes [29,30]. Although no body of evidence
concerning Grp94 Tyr-phosphorylation has been provided so far, the
Grp94-homologue, Hsp90, appears to be regulated by Src-mediated
Tyr-phosphorylation in biologically relevant conditions, such as sperm
capacitation [31] and NO release from endothelial cells [32].
Our investigation was performed using the myogenic C2C12 cell
line, awidely adopted in vitromodel of skeletal muscle differentiation,
since the exit of myoblasts from the proliferative cycle and the
expression of muscle-speciﬁc genes are well-described events, which
may be reproduced by exposing cells to a low-serummedium [15,33].
Here we show that both the activation of the Src-kinase Fyn and the
appearance of Grp94 Tyr-phosphorylation occur few hours after the
induction of muscle differentiation. Moreover, we provide evidence
that Tyr-phosphorylation of Grp94 is catalyzed by an ER luminal Fyn
and is followed by the chaperone translocation to the Golgi apparatus
and the plasma membrane compartments.
2. Materials and methods
2.1. Materials
[γ33P]ATP was from Amersham Biosciences (Little Chalfont, UK).
PP2 (4-amino-5(4chlorophenyl)7-(t-butyl)pyrazolo[3,4-d]pyrimidine),
PP3 and SU6656 (2-oxo-3-(4,5,6,7-tetrahydro-1 H-indol-2-ylmethy-
lene)-2,3-dihydro-1H-indole-5-sulfonic acid dimethylamide) were
purchased from Calbiochem (Darmstadt, Germany), and protease
inhibitor cocktail from Boehringer (Mannheim, Germany). OptiPrep™
was from Accurate Chemical and Scientiﬁc Company (Westbury, NY).
Anti-Grp94 monoclonal antibody 3C4 (IP and immunoﬂuorescence
experiments) was obtained after immunization with a recombinant
polypeptide as previously described [34]. Monoclonal anti-Grp94
(clone 9G10) (IP and immunoﬂuorescence experiments), polyclonal
anti-Grp94 antibody reactive with the C-terminus (SPA-851) (Western
blot, immunoﬂuorescence and immunogold analyses), and anti-
calreticulin antibody were obtained from Stressgen (S. Diego, CA).
Anti-Src, anti-Lyn, anti-Fgr and anti-Lck, anti-calnexin C-terminus,
anti-MHC (myosin heavy chain) and non-immune mouse immunoglo-
bulins were obtained from Santa Cruz Biotechnology (Santa Cruz, CA).
Anti-Fyn antibodies for WB and IP experiments were from Santa Cruz
Biotechnology (monoclonal and polyclonal) and from Upstate (Dundee,
UK) (polyclonal). Monoclonal and polyclonal anti-Fyn used for
immunoﬂuorescence and immunogold analysis were from Santa
Cruz and BD Biosciences (San Diego, CA). Monoclonal anti-GM130
was BD Biosciences. Anti-phosphotyrosine (PY-20) monoclonal anti-
body was obtained from Transduction Laboratories (Lexington, KY).
Anti-PMCA (Plasma Membrane Ca-ATPase) and anti-Complex II were
from Upstate and Molecular Probes (Eugene, OR), respectively.
Monoclonal antibody RV-C2 was speciﬁc for cardiac troponin T [15].
Anti-mouse and anti-rabbit peroxidase-conjugated antibodies were
from Amersham Biosciences. Monoclonal anti-β-actin and anti-mouse
immunoglobulins conjugated with agarose were obtained from Sigma
(Dorset, UK). λPPase phosphatase was purchased from Sigma. Anti-
rabbit IgG gold conjugated (15 nm) and anti-mouse IgG gold
conjugated (10 nm) were obtained from Sigma. Anti-rat IgG TRITC
Conjugate and anti-mouse IgG FITC Conjugate were from Sigma and
Santa Cruz Biotechnology, respectively. cdc2 (6–20) synthetic peptide
was kindly provided by Prof. Oriano Marin (University of Padova, Italy).2.2. Cell culture
Murine myogenic C2C12 cells (ECACC) were grown in prolifera-
tion medium [Dulbecco's modiﬁed Eagle medium (DMEM) contain-
ing 10% fetal calf serum, L-glutamine and antibiotics (Sigma)] as
previously described. Skeletal muscle differentiation was induced by
growth in the presence of low-serum medium (DMEM with 2% horse
serum and 0.5 μg/ml insulin). In parallel, control cells (differentiation
time 0) were grown in freshly renewed proliferation medium for
additional 24 h; only non-conﬂuent cultures of proliferating cells
were utilized. Control assays of experiments containing PP2, PP3 and
SU6656 routinely contained the same amount of vehicle used for
inhibitor addition. When cells were cultured with 10 μM PP2, fresh
inhibitor was added to the culture medium every 12 h and 4 h before
the use.
2.3. Western blotting analysis
Equal amounts of samples (25 μg) were run in 8% linear SDS-PAGE,
transferred to nitrocellulose, saturated with 1% Blocking Reagent,
incubated with the indicated antibody followed by the appropriate
peroxidase-conjugated secondary antibody and developed using an
enhanced chemiluminescent detection system (ECL, Amersham
Biosciences). Immunostained bands were quantiﬁed by Image Station
440 (Kodak).
2.4. Immunoprecipitation of Grp94 and Src tyrosine kinases
Cells (7×105 for each assay) were seeded in 10 cm Petri dishes and
grown in proliferation medium for 3 days before switching to
differentiation medium. At the indicated differentiation times, cells
were suspended for 1 h at 4 °C in 0.5 ml of buffer A (20 mM Tris–HCl,
pH 7.5, 10% glycerol, 1 mM EDTA, 150 mM NaCl, 1 mM sodium
orthovanadate and protease inhibitor cocktail) containing 1% Nonidet
P-40. After centrifugation, equal amounts of supernatants were
supplemented with 0.5 ml of buffer A and immunoprecipitation was
performed for 2 h in the presence of the speciﬁc antibody. Grp94
immunoprecipitation was performed with 3C4 or 9G10 antibodies as
indicated. The immunoprecipitated proteins were separated by SDS/
PAGE and immunostained with the appropriate antibody.
2.5. Kinase activity assay of Src-immunocomplexes
Tyrosine kinase assays of the immunocomplexes obtained, as
above described, with the antibodies raised against different Src-
kinases were performed in 30 μl of incubation mixture containing
50 mM Tris/HCl, pH 7.5, 5 mM MnCl2, 30 μM γ[33P]ATP (speciﬁc
activity 1000 dpm/pmol), 100 μM sodium orthovanadate and
200 μM cdc2(6–20) peptide as a substrate [36]. Following incu-
bation for 5 min at 30 °C, samples were subjected to SDS/PAGE (15%
gels) and peptide phosphorylation was evaluated using an Instant
Imager.
2.6. Puriﬁcation of Fyn tyrosine kinase, and native and recombinant
Grp94
Fyn was puriﬁed from rat brain as described for Fyn puriﬁcation
from rat spleen [35]. Native Grp94 was puriﬁed from rat liver as
described [21]. An almost complete recombinant Grp94 molecule
(717 amino acids) was puriﬁed from bacteria transformed with
rabbit grp94 cDNA clone 2.52 inserted into the bacterial expression
vector pQE (Qiagen), following previously described procedures
[34]. The resulting protein contained a polyhistidine sequence
(MRGSHHHHHHGSGCRNSARA) necessary for protein puriﬁcation
and was 86 amino acids shorter at the N-terminus than murine
Grp94. Apparent Mr of recombinant Grp94 in SDS-PAGE was 82,000.
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Both native and recombinant Grp94 (200 ng) were phosphorylated
by Fyn tyrosine kinases at 30 °C in 30 μl of phosphorylation medium
[50 mM Tris/HCl, pH 7.5, 5 mM MnCl2, 30 μM γ[33P]ATP (speciﬁc
activity 1000 dpm/pmol)]. The reactionswere stopped at the indicated
times and the samples were subjected to SDS/PAGE (8% gels). Protein
phosphorylation was evaluated either by analysis with Instant Imager
(Packard instrument Company, Meriden, CT) or by counting the
radioactive Grp94-bands in a Scintillation Counter.
2.8. Isolation of cellular microsomes
About 6×106 C2C12 cells, grown in differentiation medium for 6 h,
were sonicated in 1 ml of isotonic buffer B (50 mM Tris/HCl, pH 7.5,
0.25 M saccharose, 1 mM orthovanadate and protease inhibitor
cocktail). Cell debris and nuclei were pelleted by centrifugation at
1,000 g for 10 min. The supernatant was further centrifuged at
100,000 g for 1 h to separate the cytosol from microsomes.
2.9. 2-D gel electrophoresis of microsomal proteins treated without and
with λPPase phosphate
Cellular microsomes, prepared as in section 2.8, were resuspended
for 1 h at 4 °C in buffer A without sodium orthovanadate. 100 μl of
cellular lysate, corresponding to 200 μg protein, were added to 60 μl of
20 mM MnCl2 and 60 μl of λPPase buffer, and then brought to a ﬁnal
volume of 600 μl with deionized water. The mixture was divided into
two aliquots and 1000 units of λPPase were added to one of the
aliquots. After 45 min incubation, phosphatase activity was stopped
by adding phosphatase inhibitor cocktails 1 and 2, and 1 mM sodium
orthovanadate to the samples, which were then treated with acetone
at −20 °C. Precipitated proteins were solubilized in focusing buffer for
30 min (9 M urea, 2 M thiourea, 4% CHAPS, 65 mM DTT, 0.5% carrier
ampholytes, pH 3–10). 125 μl of the solubilized samples were
rehydrated and simultaneously loaded on the IPG strip (ReadyStrip
IPG Strips 7 cm pH 3–6, Bio-Rad), at 50 V for 12 h. The voltage was
increased to 4000 V and focused for a total of 25,000 V/h using Protean
IEF Cell (Bio-Rad). Immediately after being focused, IPG strips were
equilibrated in 6 M urea, 2% SDS, 0.375 mM Tris, pH 8.8, 20% glycerol,
2% DTT for 10 min and subsequently in 6 M urea, 2% SDS, 0.375 mM
Tris, pH 8.8, 20% glycerol, 2.5% IAA for 10 min. The second dimension
separation was run on 10% SDS-PAGE using the Mini Protean 3 Cell
(Bio-Rad) at 25 mA/gel. After electrophoresis, gels were subjected to
Western Blot analysis by immunostaining with anti-P-Tyr and anti-
Grp94 antibodies.
2.10. Puriﬁcation of Grp94 from differentiating myoblasts
Microsomes were isolated from 6 h differentiating myoblasts
(36×106 cells) as described in section 2.8. Grp94was puriﬁed from the
microsomal proteins by subsequent chromatographic steps: DEAE-
Sepharose (5×1 cm), Heparin-Sepharose (5×1 cm) and FPLC-Super-
dex S200 (30×1.5 cm), as previously described [21]. To protect the
extent of Grp94 Tyr-phosphorylation, the column buffers contained
phosphatase inhibitor cocktail and 0.1 mM sodium orthovanadate.
Comparable aliquots of the Grp94 containing fractions, eluted from
each column, were lyophilized and analyzed for both anti-P-Tyr and
Grp94 immunostaining.
2.11. Immunolocalization of Grp94 and Fyn by ﬂuorescence microscopy
C2C12 cells were grown on coverslips in proliferation or differ-
entiationmedium for 6 h in absence or presence of 10 μMPP2 as above
described, washed twice with PBS (1 mM Na2HPO4, 1.8 mM KH2PO4,
140 mM NaCl and 2.7 mM KCl, pH 7.4), and ﬁxed with 2%paraformaldehyde for 5 min at room temperature. Myoblasts were
simultaneously blocked and permeabilized with 3% bovine serum
albumin, 0.2% Triton X-100 in PBS for 10 min at 4 °C, and subsequently
probed with the indicated primary antibodies supplemented with 1%
bovine serum albumin for 1 h at 37 °C. After twowashes with PBS, Fyn
or GM130 labeling was revealed by incubation with the appropriate
ﬂuorescein isothiocyanate secondary antibody, whereas Grp94 label-
ing was revealed with tetramethylrhodamine isothiocyanate or Texas
red anti-immunoglobulins conjugates. Nuclei were counterstained by
Hoechst 33258. Coverslips were then mounted in FluorSave reagent™
for the ﬂuorescence microscopic observation of cells that was carried
out using a Zeiss Axiovert 100 (Zeiss, Oberkochen, Germany) equipped
with a digital CCD videocamera AxioCam Hr (Zeiss). Data were
acquired and analyzed by AxioVision software (Zeiss). Confocal
microscopy analysis was performed by means of a BioRad Radiance
2000 microscope equipped with argon and helium lasers, allowing
separate collection of green ﬂuorescence (Argon laser at 488 nm, with
HQ 530/60 ﬁlter) and of red ﬂuorescence (Green Helium laser at
543 nm, with E570 LP ﬁlter) of the same microscopic ﬁeld. After
Kalman processing of 5 scans (Lasersharp software), images were
collected and subsequently merged using Adobe Photoshop.
2.12. Localization of Fyn and Grp94 by immunogold ultramicroscopic
analysis
Proliferating C2C12 cells were ﬁxed for 2 h in 4% paraformaldehyde
and 0.25% glutaraldehyde in 0.1 M PBS, pH 7.2, post-ﬁxed for 1 h in 1%
osmium tetroxide in the same buffer, dehydrated in ethanol, and
embedded in London resinwhite. Ultrathin sections picked up on gold
grids were deosmicated with sodium metaperiodate, washed with
0.01 M PBS, pH 7.2, incubated for 20 min on 1% bovine serum albumin
in PBS, and treatedwith primarymonoclonal antibody against Fyn and
primary polyclonal antibody against Grp94. After washing with PBS,
sections were incubated with colloidal gold (15 nm) conjugated with
goat anti-mouse IgG and with colloidal gold (10 nm) conjugated with
goat anti-rabbit IgG. Sections were then stained with uranyl acetate
followed by lead citrate and examined under the electron microscope.
Parallel sections were incubated only with gold secondary antibodies
to evaluate the extent of background staining. The subcellular
distribution of 15 nm gold particles relative to Fyn labeling was
further analyzed counting the particles colocalized with Grp94 and
expressing this value as the percentage of total 15 nm gold grains.
2.13. Isolation of subcellular fractions by discontinuous gradient
About 10×106 C2C12 cells were disrupted by two different methods
a) lysis by Dounce homogenization in 1 ml of cold 10 mM Tris-acetate,
pH 7.4, followed by immediate addition to 0.25 M sucrose, 1 mM
MgCl2, 1 mM orthovanadate and protease inhibitor cocktail (Fig. 4C,
Fig. 5A and B; b) mild sonication in 1 ml of buffer B (50 mM Tris/HCl,
pH 7.5, 0.25 M saccharose, 1 mM orthovanadate and protease inhibitor
cocktail) (Fig. 5D and Fig. 6). Cell debris and nuclei were pelleted by
centrifugation at 1,000 g for 10 min. The supernatant was then
centrifuged for 1 h at 100,000 g to separate the cytosol from the post-
nuclear particulate fraction, which was resuspended in 200 μl of the
isotonic buffer B and overlaid onto a discontinuous gradient performed
using OptiPrep™ as described elsewhere [37]. The discontinuous
gradient was prepared using 30, 25, 15 and 10% OptiPrep™ solved in
50 mM Tris/HCl, pH 7.5, containing protease inhibitor cocktail. After
centrifugation at 100 000 g for 3 h at 4 °C, the gradient was removed in
15 equal fractions collected from the top of the gradient. The
identiﬁcation of the different subcellular fractions and the analysis of
their puriﬁcation degree were performed by immunoblotting aliquots
of the gradient resulting fractions with the following organelle-speciﬁc
antibodies: anti-PMCA (plasma membrane), anti-GM130 (Golgi appa-
ratus), anti-calreticulin (ER) and anti-Complex II (mitochondria).
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Chemical cross-linking was performed on intact C2C12 cells
differentiating for 6 h (1×106 for each assay) using the cell permeant
NHS-ester DSP (Pierce) as cross-linker. After adequate rinsing with
PBS, culture plates were exposed for 30 min at room temperature to
200 μg/ml DSP, pre-dissolved in DMSO, and added to PBS in order to
achieve a DMSO ﬁnal concentration less than 0.1%. Control plates were
added with DMSO only. Reaction was stopped by adding Tris 1 M
pH7.5. After further rinsing with cold PBS cells were lysed with 1 ml
buffer A added with antiproteases and processed for immunopreci-
pitation as described in section 2.4 using polyclonal anti-Fyn antibody
from Santa Cruz. After immunoprecipitation, the thiol bound within
the DSP linker was cleaved by boiling immunoprecipitated agarose
beds for 5 min in the presence of 5% β-mercaptoethanol and analyzed
by SDS/PAGE.
2.15. Sodium carbonate extraction
ER membranes of 6 h differentiating C2C12 cells were separated
from the soluble proteins and by other cellular organelles by the
above-described protocol of subcellular fractionation. The two more
inner fractions out of four containing ER vesicles were collected,
diluted to reach 8% OptiPrep™ and centrifugated. The pellet was then
resuspended in 50 μl of 100 mM sodium carbonate, pH 11.5, and
incubated on ice for 30 min. The suspensionwas centrifuged for 1 h at
200,000 g at 4 °C. The pellet, which represented ER membrane, was
rinsed with cold water and analyzed by Western blot. Proteins tightly
attached to the ER membranes and present in the ER lumen were
recovered from the supernatant by the addition of trichloroacetic acid
to a ﬁnal concentration of 10% and analyzed by Western blot.
2.16. Proteinase K treatment of ER fraction
The two more inner fractions out of four containing ER vesicles,
isolated by the above-described subcellular fractionation on dis-
continuous gradient, were collected, diluted to reach 8% OptiPrep™
and centrifuged. The pellet was then resuspended in 50 μl of isotonic
buffer (50 mM Tris/HCl, pH 7.5, 0.25 M saccharose, 1 mM orthova-
nadate) and treated without and with 50 ng/ml proteinase K either in
the absence or presence of 0.5% Triton X-100 at room temperature for
30 min.
2.17. Statistical analysis
Data are presented as mean±SD and compared using one-way
analysis of variance (ANOVA) followed by Bonferroni post hoc test. A
pb0.05 was considered as statistically signiﬁcant. All statistics were
performed using GraphPad Prism (version 4) statistical software
(GraphPad Software; San Diego, CA).
3. Results
3.1. Fyn activation precedes the increase of the tyrosine kinase
protein-level occurring during myoblast differentiation
The expression of several Src-kinases was examined at the protein-
level during C2C12 differentiation. To this purpose, cells were lysed at
various differentiation times and analyzed by Western blot with
antibodies speciﬁc for the following members of the Src family: Fyn,
Lyn, Src, Fgr and Lck. The total amount of Fyn and Lyn increased
signiﬁcantly after 12-hour differentiation reaching about 3.5-fold and
2-fold, respectively, as compared to proliferating cells (Fig. 1A). The
protein-level of these two tyrosine kinases remained elevated till later
stages of differentiation (48–72 h), when C2C12 myoblasts initiated to
form multinucleated myotubes. In contrast to Fyn and Lyn, the totalamount of Src, Fgr and Lck was similar in undifferentiated and
differentiating cells (Fig. 1A).
We next analyzed the activity of the different Src tyrosine kinases
during myoblast differentiation using the Src-speciﬁc peptide-sub-
strate cdc2(6–20). The kinase activity displayed in vitro by immuno-
precipitated Fyn and Lyn (IP) demonstrated that these enzymes
displayed a negligible activity in proliferating cells, whereas the
switching to the differentiation medium triggered their activation
(Fig. 1B). At variance, no effect was observed in differentiating cells on
the activity of Src, Fgr and Lck tyrosine kinases (Fig. 1B). The activation
of Fyn appeared remarkable since it was already detectable 2 h after
switching to the differentiation medium and peaked at 6 h of
differentiation reaching about 10-fold the basal activity detectable in
proliferating cells. After 72-hour differentiation Fyn displayed about
60% of the maximal kinase activity (Fig. 1B). Conversely, activation of
Lyn started at 6-hour differentiation and slowly reached 4-fold the
amount observed in proliferating cells (Fig. 1B).
3.2. Grp94 undergoes a transient Fyn-mediated Tyr-phosphorylation
during C2C12 cell differentiation
To assess whether Tyr-phosphorylation of Grp94 occurs in skeletal
muscle cells during differentiation we ﬁrst analyzed whole cellular
lysates, because both Grp94 and Src-kinases were described to be
resident in different subcellular fractions. To this purpose, Grp94 was
immunoprecipitated from proliferating and differentiating C2C12
cells, resolved by SDS/PAGE and immunostained with anti-phospho-
tyrosine (P-Tyr) antibody. Whereas no Grp94 Tyr-phosphorylation
was detectable in proliferating myogenic cells, the switching to the
differentiation medium triggered both Tyr-phosphorylation and an
about 2-fold increase in protein-level of Grp94 (Fig. 2A). Grp94 Tyr-
phosphorylation was detectable as soon as 2 h after induction of
differentiation, peaked at 6 h and then gradually declined in the
following 72 h, whereas Grp94 protein-level increased signiﬁcantly
after 12 h of differentiation. Grp94 Tyr-phosphorylation preceded
muscle-speciﬁc gene expression (Fig. 2B), whereas the increase in
Grp94 protein-amount was concomitant with the accumulation of
muscle-speciﬁc proteins, such as troponin T (TnT) and myosin heavy
chain (MHC) (Fig. 2A and B).
To further support that Grp94 was Tyr-phosphorylated during the
differentiative process, six-hour differentiating C2C12 cells were
sonicated in isotonic buffer and microsomes were isolated as detailed
inMaterial andmethods. Microsomal proteins were then separated by
two-dimensional gel electrophoresis (2-DE), immunoblotted with
anti-P-Tyr antibody and reprobed with anti-Grp94 antibody. A spot,
which displayed the expected mobility of Grp94 (pIGrp94=4.95) and
interacted with both anti-P-Tyr and anti-Grp94 antibodies, was
apparent (Fig. 2C, panels a and c). As expected for the phosphorylated
and more acidic form of Grp94, the anti-P-Tyr spot was superimposed
only on the left part of the anti-Grp94 spot (Fig. 2C, panels a and c). To
further validate the occurrence of Grp94 Tyr-phosphorylation, micro-
somal proteins were dephosphorylated by treatment with the broad
speciﬁcity protein phosphatase λPPase and then subjected to 2-DE.
The analysis of the dephosphorylated sample showed that the spot
corresponding to Grp94 (Fig. 2C, panel d) was not recognized by anti-
P-Tyr immunostaining (Fig. 2C, panel b) conﬁrming the expected
protein dephosphorylation.
To provide additional evidence that Grp94, and not a contaminat-
ing protein, undergoes Tyr-phosphorylation, the chaperone was
puriﬁed from the microsomes of 6 h differentiating myoblasts
following the same puriﬁcation procedure adopted to obtain a
pure Grp94-band from rat liver as judged by MS/MS spectra [21].
Grp94 containing fractions, eluted from the three different columns
DEAE-Sepharose, Heparin-Sepharose and FPLC-Superdex S200, were
analyzed by immunostaining with anti-P-Tyr antibody followed by
anti-Grp94 antibody (Fig. 2D), and the anti-P-Tyr/anti-Grp94 ratios
Fig. 1. Protein levels and enzyme-activity of different Src-kinases during myoblast differentiation. (A) C2C12 cells, cultured in differentiating medium for the indicated times, were
lysed and 25 μg of cell lysates were subjected to SDS/PAGE, transferred to nitrocellulose membranes and immunostained with the indicated Src-kinase antibodies. Labeling for beta-
actinwas shown as a reference for sample loading. Blots are representative of ﬁve separate experiments. Means and SEM of densitometric values, expressed as percentage relative to
the kinase protein-amount present in proliferating cells, are reported above the relative bands. (B) In parallel, 100 μg of cell lysates were immunoprecipitated with the indicated Src-
kinase antibodies. Tyrosine kinase activity of the immunocomplexes was then tested in vitro toward cdc2 (6–20), a peptide speciﬁc for Src kinases, as described under Materials and
methods. Reported values represent mean±SEM of four separate experiments. pb0.05 (⁎), pb0.01 (⁎⁎) and pb0.001 (⁎⁎⁎) vs. proliferating C2C12 cells (time=0).
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Fig. 2D). The ﬁnding that the P-Tyr immunostaining overlapping the
Grp94-band did not decrease during the puriﬁcation steps is
consistent with the conclusion that the anti-P-Tyr antibody cross-
reacts with Grp94.
The combined use of two structurally unrelated inhibitors of a
protein kinase has been demonstrated to be a useful tool in cell assays
for a highly selective identiﬁcation of this protein kinase signaling
[38]. Therefore, to evaluate the possible involvement of the Src-kinase
Fyn in the Tyr-phosphorylation of Grp94, C2C12 cells were grown in
differentiation medium containing the Src-selective inhibitors PP2 or
SU6656. Cells were then analyzed for both Fyn activity and Grp94 Tyr-
phosphorylation. As compared to untreated cells, Fyn activation
detectable in differentiating myoblasts (Fig. 3A, columns 1–3) was
abrogated in cells treated with the two inhibitors (Fig. 3A, columns 4–
6 and 7–9). In parallel, Grp94 Tyr-phosphorylation elicited in
differentiating myoblasts was abolished in cells cultured with PP2 or
SU6656 (Fig. 3B, compare lanes 1–3 with 4–6 and 7–9) providing
indirect evidence that Fyn represents a likely candidate for Grp94 Tyr-
phosphorylation. It is interesting to note that neither of the inhibitors
affected the amount of immunoprecipitated Fyn and Grp94 (Fig. 3A
and B). The ﬁnding that PP3, an inactive analogue of PP2, did not affect
Grp94 Tyr-phosphorylation (data not shown), ruled out the hypoth-
esis of a non-speciﬁc effect of the inhibitor PP2.
To further validate the hypothesis that Grp94 is a substrate of Fyn,
the phosphorylation activity of Fyn, puriﬁed from rat brain, was tested
in vitro towards both native Grp94 puriﬁed to homogeneity from rat
liver [21] and a recombinant protein expressing an almost complete
rabbit Grp94, which lacked the ﬁrst 86 amino acids at the N-terminus(apparent Mr=82,000), when compared to murine Grp94 [15,34].
Time course experiments showed that Fyn phosphorylated both
proteins reaching the high stoichiometry of about 2 mol Pi/mol
substrate (Fig. 3C).
3.3. Fyn colocalyzes with Grp94 in the ER lumen of proliferating
C2C12 cells
We then analyzed the subcellular localization of Fyn and Grp94 in
proliferating C2C12 cells using different approaches. Confocal micro-
scopy showed that Grp94 (red ﬂuorescence) displayed a punctate
staining dispersed throughout the cytosol, consistent with ER
localization. Fyn immunolabeling (green ﬂuorescence) also appeared
discrete and spread to the plasmamembrane (Fig. 4A). Merging
showed that a substantial amount of Fyn colocalized with Grp94,
especially in the proximity of the nucleus, whereas both staining
showed a complementary distribution in the more peripheral regions
of the cell (Fig. 4A, merge). To further delineate the distribution of the
two proteins in proliferating C2C12 cells, we performed post-
embedding immunoelectronmicroscopic analysis using double immu-
nogold labeling. Whereas no staining was observed in the absence of
the primary antibodies (Fig. 4B, left), immunogold decoration of Fyn
(15 nm gold probe) was apparent at the cytosolic side of the plasma
membrane and adjacently to and inside vesicular structures in the
cytosol (Fig. 4B, right). The immunolabeling of Grp94 (10 nm gold
probe) appeared to be lumenal, when the vesicular structure was
evident. Some of these vesicles displayed also luminal labeling for Fyn
(arrows in Fig. 4B, right) suggesting that both proteins were present in
the lumen of the same vesicles. Data showed that the number of
Fig. 2. Grp94 undergoes Tyr-phosphorylation during myoblast differentiation. (A,B) C2C12 differentiating cells were lysed at the indicated times. (A) Cell lysates were
immunoprecipitated with anti-Grp94 antibody. The immunocomplexes were blotted, immunostained with anti-P-Tyr antibody and reprobed with SPA-851 anti-Grp94 antibody.
(B) 25 μg of total cellular lysates were immunoblotted with the antibodies raised against troponin T (TnT) and myosin heavy chain (MHC). Labeling for β-actin was shown as a
reference for sample loading. Panels A and B are representative of four separate experiments. (C) Microsomes, isolated from C2C12 cells cultured in differentiating medium for 6 h
as detailed in Materials and methods, were incubated without (a, c) or with λPPase phosphatase (b, d) and then analyzed by Western blotting after protein separation using 2D-
electrophoresis, as detailed in Materials and methods. Blots were stained with anti-P-Tyr antibody (a, b) and then reprobed with anti-Grp94 antibody (c, d). The arrow indicates the
position of Grp94. The ﬁgure is representative of three separate experiments. (D) Grp94 was puriﬁed from the microsomes of 6 h differentiating myoblasts by the subsequent
chromatographic steps: DEAE-Sepharose (lanes 1, 2), Heparin-Sepharose (lanes 3, 4) and FPLC-Superdex S200 (lanes 5, 6) columns, as described in Materials and Methods.
Comparable amounts of Grp94-containing fractions eluted from each step, as judged by anti-Grp94 immunostaining, were lyophilized and solved in 200 μl of 50 mM Tris/HCl,
pH 7.5. Then, 15 (lanes 1, 3, 5) and 30 μl (lanes 2, 4, 6) of each fraction were subjected to SDS/PAGE and analyzed by Western blotting with anti-P-Tyr antibody followed by anti-
Grp94 antibody. In the low part of the panel the ratios of the densitometric values of anti-P-Tyr spots over those of anti-Grp94 spots are reported. Reported values are the
means of three separate experiments with SEM less than 12%.
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with Grp94 was about 30% of the total Fyn particles (49 vs. 162,
respectively, counted on 20 micrographic ﬁelds).
To better deﬁne the microsomal compartment where Fyn and
Grp94 might colocalize, proliferating C2C12 cells were disrupted by
Dounce homogenization and, after nucleus removal, the cytosol was
separated from the particulate fraction. The cell compartmentscontained in the latter fraction were then separated by ultracentri-
fugation on OptiPrep™ discontinuous gradient as detailed inMaterials
andmethods. To identify the different subcellular fractions, aliquots of
the gradient fractions were blotted and immunostained with the
following organelle-speciﬁc antibodies: anti-PMCA (Plasma Mem-
brane Ca++ ATPase), anti-GM130 (Golgi apparatus), anti-calnexin (ER)
and anti-complex II (mitochondria) (Fig. 4C). The analysis of Grp94
Fig. 3. Grp94 is a potential substrate of Fyn in differentiating myoblasts. (A) C2C12 cells were grown in differentiating medium for 0, 6, or 24 h with either vehicle (lanes 1–3) or 10 μM
PP2 (lanes 4–6) or SU6656 (lanes 7–9). Cells were then lysed and cellular lysates were immunoprecipitated with anti-Fyn antibody and the kinase activity of the immunocomplexes
was tested in vitro as detailed underMaterials andmethods (columns of panel A). Reported values represent mean±SEM of four separate experiments; pb0.001 (⁎⁎⁎) vs. proliferating
C2C12 cells (time=0). In parallel experiments, the amount of immunoprecipitated Fynwas analyzed byWestern blotting with anti-Fyn antibody (blots of panel A). (B) Cellular lysates
obtained as in (A) were immunoprecipitated with anti-Grp94 antibody. The blots of the immunocomplexes were immunostained with anti-P-Tyr antibody and reprobed with SPA-
851 anti-Grp94 antibody. The ﬁgure is representative of four separate experiments. (C) Time courses of phosphorylation of recombinant (solid circles) or native (solid squares) Grp94
catalyzed by Fyn. The preparations of Fyn (from rat brain), native Grp94 (from rat liver), recombinant rabbit Grp94, and the protein phosphorylation assays were performed as
described in Materials and methods. Reported values represent mean±SEM of three separate experiments.
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only in the ER compartment, whereas Fyn was resident in all the
subcellular fractions (Fig. 4C), consistently with the immunoﬂuores-
cence analysis (Fig. 4A). Fyn protein localized mostly at the plasma
membrane (gradient fractions 1, 2) and a substantial amount of the
kinase was present in the ER compartment (gradient fractions 9–11).
Comparable results concerning Grp94 and Fyn distribution in
proliferating C2C12 cells were obtained following cell disruption by
sonication in isotonic buffer (see Fig. 6A below). Although we cannot
exclude that some Grp94 may leak during fractionation, and, there-
fore, become undetectable in other non-ER compartments, both
protocols show that this chaperone mostly localized in the ER
compartment of proliferating C2C12 cells.
The parallel analysis of Lyn (p53 and p56 isoforms) distribution
showed that this Src-kinase, which was also mostly resident in the
plasma membrane, was distributed differently than Fyn in the other
fractions (Fig. 4C). While a substantial amount of Lyn was present inthe Golgi apparatus (gradient fractions 5–8), a very low level localized
in the ER (gradient fractions 9–11).
3.4. Fyn interacts with and phosphorylates Grp94 in the ER lumen of
differentiating C2C12 cell
To provide direct evidence that Grp94 is phosphorylated by Fyn
during myoblast differentiation, the subcellular particles of cells
differentiated at different times were isolated on OptiPrep™ gradient
as shown in Fig. 4C. The gradient fractions containing the ER vesicles
were then immunoprecipitated with either anti-Grp94 (Fig. 5A) or
anti-Fyn (Fig. 5B) antibodies and the immunocomplexes were
analyzed for the coimmunoprecipitation of Fyn and Grp94, respec-
tively. These experiments revealed that, after switching to differentiat-
ingmedium, Grp94 interactedwith Fyn (blots 1–5 of Fig. 5A and B). It is
noteworthy that Grp94 interacted onlywith the active conformation of
Fyn as demonstrated by the in vitro kinase activity exhibited byGrp94-
Fig. 4. Fyn colocalizes with Grp94 in the ER lumen of proliferating C2C12 cells. (A) Confocal microscopy of double immunoﬂuorescence staining of proliferating C2C12 cells with
polyclonal anti-Grp94 (red ﬂuorescence) and monoclonal anti-Fyn (green ﬂuorescence) antibodies. Co-localization of stainings is visualized by the orange ﬂuorescence appearing
after merging of both signals. The arrow indicates the presence of Fyn immunoreactivity in proximity of myoblast plasmamembrane. Bar: 10 μm. (B) Post-embedding double-labeling
immunoelectronmicroscopy of proliferating C2C12 cells. Labelling of Fyn antibody was visualized by 15 nm-gold conjugated secondary antibodies, whereas anti-Grp94 antibody
staining was revealed by 10 nm-gold conjugate antibodies as described in Materials and methods. Arrows indicate cytosolic vesicles whose lumen contains gold particles of both
sizes. Ctrl shows a section incubated only with the gold-conjugated antibodies. Bars: 150 nm. (C) Proliferating C2C12 cells were disrupted by Dounce homogenization and nuclei and
cytosol were separated from the particulate fraction, which was centrifuged on discontinuous OptiPrep™ gradient to separate the cellular membrane compartments, as described
under Materials and methods. Aliquots from each resulting fraction were immunoblotted with the following organelle-speciﬁc antibodies: anti-PMCA (plasma membrane), anti-
GM130 (Golgi apparatus), anti-calnexin (ER) and anti-Complex II (mitochondria). Other aliquots were immunostaining with anti-Grp94, anti-Fyn or anti-Lyn antibodies. Mean±SEM
of the densitometric analysis is reported above the relative bands. Grp94, Fyn and Lyn distribution in the different compartments is expressed as percentage relative to the total
protein-level present in the particulate fraction. The ﬁgure is representative of three separate experiments.
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amount of coimmunoprecipitated Fyn-protein was detectable at 6 h
differentiation, in parallel with the maximum of the kinase activity
detected in Grp94-immunocomplexes (blots and columns 1–5 of Fig.
5A). The interaction of Grp94with active Fynwas also conﬁrmed by the
ﬁnding that Grp94 coimmunoprecipitated with Fyn in parallel with
Fyn activation (blots and columns 1–5 of Fig. 5B). Consistently, neitherFyn-protein co-immunoprecipitated with Grp94, nor kinase activity
was detectable in both Grp94- and Fyn-immunoprecipitates, when
myoblastswere cultured in differentiatingmedium containing the Src-
inhibitor PP2 (blots and columns 6–10 of Fig. 5A and B).
To rule out the hypothesis that the interaction of Grp94 with Fyn
occurred artefactually, after cell lysis and before immunoprecipitation,
we exposed intact 6 h differentiating C2C12 cells to a cell permeable
Fig. 5. Active Fyn interacts with and phosphorylates Grp94 in the ER lumen of differentiating C2C12 cells. (A, B) C2C12 cells, grown in differentiating medium for 0, 2, 6, 12 and 24 h
with either vehicle (lanes 1–5) or 10 μM PP2 (lanes 6–10), were disrupted by Dounce homogenization and the cell particulate fraction was fractionated as described in Fig. 4C. The
central fractions (10 and 11 of Fig. 4C) containing the ER compartment were pooled, diluted to 8% OptiPrep™ and centrifuged. The pellets were resuspended with lysis buffer and
immunoprecipitated with either anti-Grp94 (A) or anti-Fyn (B) antibodies. (A) Grp94-immunocomplexes were analyzed by Western blotting with anti-Fyn antibody and reprobed
with anti-Grp94 antibody (blots of panel A). Grp94-immunocomplexes obtained in parallel experiments were analyzed for the coimmunoprecipitation of Src-speciﬁc kinase activity
using the cdc2 (6–20) peptide as a substrate as detailed in Materials and methods (columns of panel A). Reported values represent mean±SEM of three separate experiments. pb0.05
(⁎), pb0.01 (⁎⁎) and pb0.001 (⁎⁎⁎) vs. proliferating C2C12 cells (time=0). (B) Fyn-immunocomplexes were analyzed by Western blotting with anti-Grp94 antibody and reprobed
with anti-Fyn antibody (blots of panel B). Fyn-immunocomplexes obtained in parallel experiments were assayed for in vitro kinase activity (columns of panel B). Reported values
represent mean±SEM of three separate experiments. pb0.001 (⁎⁎⁎) vs. proliferating C2C12 cells (time=0). Panels A and B are representative of three separate experiments.
(C) Differentiating (6 h) C2C12 cells were cross-linked with DSP before lysis as described in Materials and methods and 150 μg of protein from whole cell lysate were processed for
immunoprecipitation with either anti-Fyn polyclonal antibodies or non-immune rabbit immunoglobulins (Rb Ig), and protein A-agarose. The panel shows Western blotting of
immunoprecipitates labelled for Grp94 (upper panel) and Fyn (lower panel). (D, E) Differentiating (6 h) C2C12 cells were disrupted by sonication and the ER vesicles were isolated as
described in (A, B). (D) The central fractions containing the ER vesicles were pooled, treated with sodium carbonate and the soluble proteins (S) were separated from the ER
membrane (M), as described under Materials and methods. The distribution of calreticulin and Grp94 were analyzed byWestern blot. Means±SEM of the densitometric analysis are
reported above Grp94 spots. pb0.001 (⁎⁎⁎) vs. soluble proteins. (E) ER vesicles were treated with 50 ng/ml proteinase K (PK), either in the absence or the presence of 0.5% Triton X-
100 (TX), as described under Materials and methods. Equal amounts of vesicles were then analyzed byWestern blotting with antibodies to calnexin, calreticulin, PMCA, GM130, and
Fyn. Similar aliquots wereWestern blotted with anti-P-Tyr antibody and reprobed with anti-Grp94 antibody. Only the region of the blot corresponding to Grp94 is shown for the anti-
P-Tyr staining. Means±SEM of the densitometric analysis are reported above the relative bands. pb0.05 (⁎), pb0.01 (⁎⁎) and pb0.001 (⁎⁎⁎) vs. the control densitometric value. The
ﬁgure is representative of three separate experiments.
247M. Frasson et al. / Biochimica et Biophysica Acta 1793 (2009) 239–252
248 M. Frasson et al. / Biochimica et Biophysica Acta 1793 (2009) 239–252chemical cross-linker and then performed Fyn-immunoprecipitation
from the cellular lysates. The coimmunoprecipitation of Grp94 with
Fyn conﬁrmed the occurrence, in intact cells, of the tyrosine kinase
interaction with the ER chaperone (Fig. 5C).
A biochemical approach was then used to conﬁrm that Grp94 is
phosphorylated by Fyn in the ER lumen. Since Grp94 has been
described to be present in the endoplasmic reticulum as a lumenal and
a transmembrane protein [9,10,12], we ﬁrst investigated whether
differentiating C2C12 cells contained Grp94 in both forms. To this
purpose, ER vesicles, isolated from differentiating myoblasts by
ultracentrifugation on discontinuous gradient as shown in Fig. 4C,
were incubated with sodium carbonate and subfractionated into the
soluble fraction (S) containing the proteins present in the ER lumen
and tightly bound to the membrane, and the ER membrane fraction
(M) containing the integral proteins [10,12]. Western blot and
densitometric analyses showed that the majority of Grp94 was
resident into ER lumen (S), while only the 12% was bound to the ER
membrane (Fig. 5D). The detection of the luminal protein calreticulin
exclusively in the ER soluble fraction demonstrated the efﬁciency of
the carbonate treatment and proved that a rather small aliquot of
Grp94 was a membrane-spanning protein in differentiating myoblasts
(Fig. 5D). To determine whether the transmembrane form of Grp94 or
the luminal one was predominantly phosphorylated by Fyn, we then
assessed the sensitivity of the ER-associated proteins to proteinase K.
ER vesicles, isolated from 6 h differentiating myoblasts by ultracen-
trifugation on discontinuous gradient, were incubated without (Ctrl)Fig. 6. Grp94 Tyr-phosphorylation is associated with the protein translocation in differentiat
differentiating medium (B, C) containing either vehicle (A, B) or 10 μMPP2 (C). Cells were the
fraction. The subcellular fractions were isolated by centrifugation of the particulate fraction o
A, B, C) Aliquots from each resulting fraction were immunoblotted with the indicated anti
containing Golgi apparatus and ER, respectively, were pooled, diluted to 8% OptiPrep™ and ce
anti-Grp94 antibody. The immunocomplexes were analyzed byWestern blot with anti-P-Tyr
four separate experiments.or with proteinase K in the absence or presence of Triton X-100 [39].
The lack of detectable ER contamination by plasma membrane and
Golgi apparatus was veriﬁed by the organelle-speciﬁc antibodies
PMCA and GM130, respectively. Samples were then analyzed by
Western blot with antibodies to Fyn, Grp94, calreticulin and the
cytosolic C-terminal fragment of the transmembrane protein calnexin
(Fig. 5E). As expected, the ER cytosolic fragment of calnexin was
completely degraded regardless of whether vesicles were solubilized
or not by Triton X-100, whereas the luminal protein calreticulin was
protected from the proteolytic enzyme in the absence of detergent. In
these conditions, a substantial amount of Fyn was not digested by
proteinase K in the absence of Triton X-100 (Fig. 5E), demonstrating
that the tyrosine kinase was also resident inside the ER. In the absence
of detergent, the amount of Grp94 immunoreactivity appeared
slightly decreased (Fig. 5E), consistently with the presence of its
transmembrane form detected after carbonate extraction (Fig. 5D).
Therefore, this partial loss of Grp94 immunoreactivity might have
origin from the digestion of its large cytosolic portion [9,10]. At
variance of the protein, the extent of Grp94 Tyr-phosphorylation was
not affected by the digestion (Fig. 5E), suggesting that only the luminal
Grp94 was Tyr-phosphorylated.
3.5. Tyr-phosphorylation of Grp94 is coupled with the protein trafﬁcking
To assess whether Grp94 Tyr-phosphorylation is involved in the
protein trafﬁcking occurring during myoblast differentiation [8,15],ing myoblats. C2C12 cells were grown in proliferating medium (A) or cultured for 6 h in
n sonicated in isotonic buffer and nuclei and cytosol were separated from the particulate
n discontinuous OptiPrep™ gradient as described in Materials and methods. (Left part of
bodies. (Right part of A, B, C) Fractions 5–7 and 9–11 of the relative glycerol gradient,
ntrifuged. The pellets were resuspendedwith lysis buffer and immunoprecipitated with
antibody and reprobedwith anti-Grp94 antibody. The ﬁgure is representative of at least
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compared with that of 6 h differentiating muscle cells. Fyn was
similarly distributed in proliferating and differentiating myoblasts
(left panel of Fig. 6A and B). In contrast, while Grp94 was detectable
only in the ER compartment of proliferatingmyoblasts (Fig. 4C and left
panel of Fig. 6A), in differentiating myoblasts a substantial amount of
the protein was detectable also in the Golgi apparatus and in the
plasma membrane fractions (left panel of Fig. 6B), demonstrating that
Grp94 translocation occurred during the differentiation process. The
retention of the luminal protein calreticulin inside the ER compart-
ment duringmyoblast differentiation (left panel of Fig. 6B) proved that
Grp94 translocationwas a speciﬁc event. Furthermore, in differentiat-
ing cells, Grp94 still present in the ER compartment as well as that
migrated to the Golgi apparatus appeared Tyr-phosphorylated (right
panel of Fig. 6B). The ﬁnding that the degree of Grp94 Tyr-
phosphorylation was much higher in the Golgi than in the ER fraction
suggested that the protein translocation was associated with its Tyr-
phosphorylation. This hypothesis was conﬁrmed by the absence of
subcellular redistribution (left part of Fig. 6C) of non-phosphorylated
Grp94 (right part of Fig. 6C) in C2C12 cells differentiating in the
presence of PP2 inhibitor.
An additional evidence for Grp94 subcellular redistribution was
provided by immunoﬂuorescence studies. In proliferating C2C12 cells
Grp94 immunoﬂuorescence appeared widely distributed in the ER
(Fig. 7A), whereas after 6 h switching to differentiation medium
intense Grp94 immunostaining appeared in the Golgi apparatus, as
judged by the co-localization with the Golgi-marker GM130 (Fig. 7B).
Furthermore, after exposure of differentiating C2C12 to PP2, the
distribution of Grp94 immunoreactivity appeared identical to that oneFig. 7. Fluorescence immunolocalization of Grp94 in the Golgi apparatus of 6 h differentiatin
differentiating medium (B, C) containing the vehicle (A, B) or 10 μM PP2 (C). Cells were dou
marker mouse monoclonal anti-GM130 antibody (green ﬂuorescence), as described in Mat
ﬂuorescence. Nuclei were counterstained with Hoechst 33258 (blue ﬂuorescence). Bar: 30 μobserved in proliferating cells (Fig. 7C), indicating that the inhibition
of Grp94 Tyr-phosphorylation abrogated the redistribution of Grp94
immunostaining in the Golgi apparatus.
4. Discussion
Recent investigations pointed to the exclusive role played by the ER
chaperone Grp94 in maturation and export of cell surface receptors
and growth factors [7,8]. Such a role appears of crucial relevance for
muscle cells, since neither muscle speciﬁcation occurred in embryo
bodies derived from grp94 knock-out ES cells [8], nor myotube
formation was observed after reduction of Grp94 levels by means of
stable transfection of myogenic cells with antisense Grp94 cDNA [15].
In particular, the latter study demonstrated that myoblast fusion
depends on the localization of Grp94 at the cell surface of
differentiating muscle cells. Here we investigated the signal(s)
involved in the subcellular redistribution of Grp94 occurring during
myoblast differentiation and we provided evidence that a major event
is represented by the Src-catalyzed phosphorylation of the chaperone.
We show for the ﬁrst time that Grp94 is a substrate of the Src-kinase
Fyn in muscle C2C12 cells and is Tyr-phosphorylated early after the
initiation of the differentiative process. Furthermore, we provide
evidence that the tyrosine kinase Fyn is present in the ER lumen,
where it interacts with and phosphorylates Grp94 and that this event
is necessary, even if may not be sufﬁcient, to promote the chaperone
translocation outside the ER compartment.
Anti-P-Tyr staining of Grp94 either immunoprecipitated or
puriﬁed from differentiating myoblasts, and phospho-proteomic
analysis of isolated C2C12 cell microsomes indicate that thisg C2C12 cells. C2C12 cells were grown in proliferating medium (A) or cultured for 6 h in
bly stained with rat monoclonal anti-Grp94 antibody (red ﬂuorescence) and the Golgi
erials and methods. Co-localization of staining is visualized by the presence of yellow
m.
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myoblast differentiative process. Treatment of differentiating C2C12
cells with two structurally unrelated Src-inhibitors proved that Src-
kinase activity is involved in Grp94 Tyr-phosphorylation in differ-
entiating myoblasts. Among the Src-kinases analyzed, we focused our
attention on Fyn tyrosine kinase on the basis of the following
evidence: i) the high phosphorylation stoichiometry reached in vitro
by Fyn towards both native and recombinant Grp94 ii) the remarkable
Fyn activation concomitant with Grp94 Tyr-phosphorylation, which
occurs in the early phases of myoblast differentiation, iii) the parallel
inhibition of Fyn activity and Grp94 Tyr-phosphorylation by Src-
inhibitors, iv) the interaction of active Fyn with Grp94 during the
differentiative process as shown by chemical cross-linking and co-
immunoprecipitation experiments v) the colocalization of Fyn and
Grp94 within the ER compartment vesicles as suggested by immuno-
electronmicroscopy and conﬁrmed by cell membrane fractionation
followed by proteolytic assays. However, we cannot exclude that a
Fyn-like kinase, displaying several properties similar to Fyn, including
apparent Mr, cross-reactivity with different anti-Fyn antibodies (two
polyclonal and one monoclonal), substrate speciﬁcity and sensitivity
to inhibitors, might be responsible for Grp94 Tyr-phosphorylation
during myoblasts differentiation.
In detail, our results indicate that the tyrosine kinase Fyn is present
in its “closed” and inactive conformation in non-conﬂuent proliferat-
ing myoblasts. As generally described for Src kinases, this conforma-
tion comes as a result of the Csk-mediated phosphorylation of the
enzyme C-terminal tyrosine, which gives rise to an intra-molecular
interaction between this phospho-residue and the kinase own SH2
domain [27,40]. The switching to differentiatingmediummakes Fyn to
adopt its “open” conformation triggering the enzyme activation,
which occurs very early in myotube formation process. The tyrosine
kinase activity, which is already high after 2 h of differentiation,
reaches the maximum at 6 h, before the coordinated expression of
muscle-speciﬁc genes, which precedes the fusion of myoblasts into
multinucleated myotubes. Subsequently, at 12 h differentiation, the
cellular protein-amount of Fyn increases, concomitant with the
expression of muscle-speciﬁc proteins, such as troponin T and myosin
heavy chain, and the increase of Grp94 protein-amount. Parallel
experiments aimed at monitoring the early stages of differentiation,
evaluated the extent of exit from the cell cycle and the activation of
muscle-speciﬁc transcription factors by mean of the presence of
nuclear labeling for p21 and myogenin, respectively. The obtained
data showed for both markers a signiﬁcant increase in the percentage
of positive cells only after 6 h permanence in differentiation medium,
thence, after the activation of Fyn tyrosine kinase and the appearance
of Grp94 Tyr-phosphorylation (our unpublished results). Our results
are consistent with and complementary to other reports showing that
the activity of the Src-kinase Fyn is necessary for differentiated
myoblasts [29,30].
The tyrosine kinase Fyn, once activated during the differentiation
process, recruits and phosphorylates Grp94. Grp94 Tyr-phosphoryla-
tion peaks at 6 h and then declines while the Grp94 expression is
increasing. Such an apparent discrepancy concerns also Fyn, whose
activity remains stable despite of the increase in its cellular level. A
possible explanation for the transient Tyr-phosphorylation of the
chaperone may be ascribable to the activation of protein tyrosine
phosphatase(s), which occurs early after Fyn-activation and affects
both Fyn activity and Grp94 Tyr-phosphorylation (our unpublished
observations). The ﬁnding that increased Grp94 expression may
follow protein post-translational changes and, therefore, sub-cellular
redistribution, was provided also by Ying et al. [41], who showed that
Grp94 migration (and secretion) preceded Grp94 increase in protein
level, when a different cell system was exposed to thapsigargin.
The occurrence of a speciﬁc interaction between Fyn and Grp94 is
anticipated by the Tyr-phosphorylation of both native and recombi-
nant Grp94 by Fyn in vitro and demonstrated to occur in the livingcell by the co-immunoprecipitation of the two proteins after
cross-linking of intact 6 h differentiating cells. The possibility that
Tyr-phosphorylation affected another protein, different from and co-
migrating with Grp94 in 2D gels, was addressed by isolating Grp94
from differentiating myoblasts adopting the same puriﬁcation
procedure, which allowed us to obtain pure Grp94 from rat liver, as
determined by MS/MS spectra [21]. Such an approach was required
since several enzymatic activities were ascribed to Grp94 itself,
including autophosphorylation, and were not belonging to the
chaperone [17,42]. Our results show that the extent of Grp94 Tyr-
phosphorylation is not reduced during the following puriﬁcation
steps counteracting the hypothesis that anti-P-Tyr immunostaining
might be ascribed to a contaminating protein. In differentiating
C2C12 cells, the interaction with Grp94 involves the Fyn active
conformation because i) Grp94-immunocomplexes display an in vitro
kinase activity, which is proportional to the amount of Fyn-protein
bound to the chaperone at the different differentiation times; ii)
inactive Fyn does not co-immunoprecipitate with the potential target
Grp94 in C2C12 cells differentiating in the presence of the Src-kinase
inhibitor PP2.
Tyrosine kinases of the Src family are generally associated with the
cytosolic surface of the cellular membranes [27] and our immuno-
ﬂuorescence and subcellular fractionation analyses indeed conﬁrm
the broad distribution of Fyn in several membrane compartments of
C2C12 cells. The possibility that ER cytosolic Fyn might interact with
ER endoluminal Grp94 by an artifact occurring during the coimmu-
noprecipitation, was ruled out by different experimental analyses. The
Grp94 chaperone is considered to exist as an ER luminal protein;
nevertheless, protein sequence analysis [43] and proteolytic assays on
isolated microsomes [5,9,10] showed that, a part of Grp94 molecules
can display a transmembrane localization, exposing the C-terminus
into the cytosol. In cardiac myocytes, Grp94 apparently displays a
completely intra-luminal localization [20]. Our experiments prove
that, in the ER of differentiating C2C12 cells, a rather small proportion
of Grp94 shows a transmembrane localization, whereas themajor part
of the chaperone is resident inside the ER. Moreover, we demon-
strated that the luminal form undergoes Tyr-phosphorylation since
the treatment of intact ER vesicles with proteinase K, which digests
proteins at the cytosolic surface, does not affect the extent of Grp94
Tyr-phosphorylation. Furthermore, the ﬁnding that a substantial
amount of Fyn is not degraded by proteinase K further supports the
hypothesis that luminal Grp94 is Tyr-phosphorylated by Fyn mole-
cules localized in the ER lumen. The presence of Fyn inside the
cytosolic membrane compartment is also supported by the immu-
noelectronmicroscopy analysis, which suggests that both Grp94 and
Fyn are present in the lumen of cytosolic vesicles and by the ﬁnding
that the Fyn interactionwith Grp94 can be revealed by chemical cross-
linking in intact 6 h differentiating cells.
Since the fractionation analysis does not reveal the presence of
Grp94 in the cis-Golgi compartment (identiﬁed by GM130 distribu-
tion) and the administration of the Src-kinase inhibitor to differ-
entiating cells apparently blocks any redistribution of Grp94 among
the different membrane compartments, we hypothesize that the
interaction of Grp94 with Fyn should occur into the ER. However, we
cannot exclude that our ER markers (calnexin and calreticulin) might
distribute also at the boundary of ER and Golgi compartments, i.e. the
intermediate compartment, in C2C12 cells. Indeed, Grp94 was
demonstrated to be present in the intermediate compartment of
NRK cells [41]. To the best of our knowledge, Fyn is the ﬁrst Src-kinase
detected inside the ER compartment. Our results together with
previous reports, which demonstrate that c-Src is associated with the
inner membrane of mitochondria in osteoclasts [39,44], suggest that
several target-substrates of Src-kinases might be resident inside the
subcellular particles. Although Fyn does not apparently carry a
recognizable signal sequence that would target it cotranslationally
to the ER, a post-translational mechanism of protein translocation into
251M. Frasson et al. / Biochimica et Biophysica Acta 1793 (2009) 239–252the ER cannot be excluded [45]. Moreover, it would be possible that
Fyn localization inside the ER might be mediated by a speciﬁc
anchoring molecule, as it has been demonstrated that c-Src is
translocated inside mitochondria by the adaptor protein Dok-4 [44].
Eventually, subcellular fractionation by ultracentrifugation and
ﬂuorescence immunolocalization showed that, whereas in proliferat-
ing myoblasts non-phosphorylated Grp94 is resident in the ER
compartment, Tyr-phosphorylation is required to release Grp94 from
the ER to the Golgi apparatus and the plasma membrane. Although
details concerning other molecules possibly involved in the translo-
cation process are out of the scope of the present investigation, the
crucial role played by Tyr-phosphorylation in Grp94 trafﬁcking is
supported by the absence of the protein redistribution outside the ER
when myoblasts are grown in differentiating medium containing the
Src-inhibitor PP2, which abrogates the chaperone Tyr-phosphoryla-
tion. Our preliminary body of evidence shows that a prolonged
exposure to PP2 apparently blocks muscle maturation, i.e. myotube
formation, in accordance with what described by Lu et al. [46].
However, this treatment does not interfere with the expression of
muscle-speciﬁc genes (our unpublished observations), suggesting
that the major role played by Grp94 during muscle differentiation
occurs through its redistribution to the secretory pathway and the
plasmalemma.
Subcellular re-localization appears to be a feature shared by
several cell chaperones to favour folding and assembly of the client
protein at the ﬁnal destination, as for example it occurs for myosin
heavy chains [47]. Although co-chaperones or the client protein may
be responsible for the guidance and redistribution of the chaperone
complex, the phosphorylation of the chaperone itself, usually
occurring as a consequence of the exposure to stress, appears also to
be involved in re-directing it to different subcellular compartments
[48,49]. It has to be mentioned, however, that the biological
signiﬁcance of chaperone redistribution remains to be determined
in several cases. Grp94 relocalization, which occurs so early after the
initiation of muscle differentiation, might be involved in maturation
and secretion of muscle growth factors, whose severe reduction in
Grp94 knock out mouse embryos failed to induce muscle cell
differentiation [8]. Consistently, it has been shown that the severe
inhibition of Src-activity induced by PP2 correlates with impaired
myoblast differentiation and myotube formation in C2C12 and L6
skeletal muscle cells [46,50]. On the other hand, L6 skeletal muscle
cells with reduced expression of the protein tyrosine-phosphatase-
alpha, an activator of Src-kinase(s), fail to undergo fusion and form
myotubes [46].
Together, our results demonstrate that the Src-kinase Fyn plays an
early role during the differentiation of muscle cells and is responsible
for the Tyr-phosphorylation of Grp94, which occurs inside the ER
compartment and is necessary, even if not sufﬁcient, to initiate the
subcellular redistribution of this ER chaperone.
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